Bullous Emphysema


Article Author:
Najam Siddiqui


Article Editor:
Vinod Nookala


Editors In Chief:
Yvonne Carter
Jason Wallen


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Frank Smeeks
Kristina Soman-Faulkner
Trevor Nezwek
Radia Jamil
Patrick Le
Sobhan Daneshfar
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
5/18/2019 10:30:26 PM

Introduction

The definition of a bulla is an air-filled space of > 1 cm in diameter within the lung which has developed because of emphysematous destruction of the lung parenchyma. Emphysema is a limitation in airflow associated with a loss of the distal lung architecture with permanent enlargement of the alveolar space distal to the terminal bronchiole.[1] Eighty percent of patients presenting with bullae have associated pulmonary emphysema, and this entity, therefore, is referred to as bullous emphysema. It is a subset of chronic obstructive pulmonary disease (COPD), an obstructive airway disease, associated with high mortality. It has bullae associated with diffusely abnormal lung parenchyma because of COPD. It causes high costs to healthcare systems associated with frequent visits to healthcare providers and frequent hospitalizations secondary to exacerbations.

Etiology

The two most common causes of bullous emphysema are smoking and alpha-1 antitrypsin deficiency (A1AD or AATD), an inherited autosomal codominant genetic condition.[2] Less common causes of underlying emphysematous destruction of lung parenchyma are marijuana or crack cocaine smoking or intravenous drug abuse leading to inflammatory or destructive damage to the alveolus.

Epidemiology

Bullous emphysema affects greater than five percent of the population with the worldwide prevalence being almost 12 percent in adults over the age of 30. It is also ranked third in causes of death in the United States and kills more than 120,000 individuals a year.

Pathophysiology

The pathophysiology of bullous emphysema is intimately related to the chronic inflammation of the distal airspaces mostly secondary to insult, i.e., cigarette smoke, which results in a breakdown of the alveolar walls which subsequently leads to permanent enlargement of airspaces.  Eventually, this can lead to a decline in gas exchange and an airflow limitation through decreased elastic recoil of the chest wall.  There is often an increased amount of goblet cells in the airways with hyperplasia of the mucous glands, fibrosis, and airway collapse secondary to the loss of tethering from alveolar destruction.  This decrease in gas exchange and airflow limitation eventually leads to chronic hypoxia and hypercarbia in these patients.

Histopathology

The histopathology of emphysema is intimately related to the integrity of the lung's integral epithelial cell barrier.  After an insult upon this barrier such as by cigarette smoke, the resulting inflammatory response transports antigens to the bronchial associated lymphatic tissue layer. There, the macrophages and neutrophils release enzymes such as elastase which leads to the eventual destruction of the lung's epithelial barrier. 

Emphysema is often sub-classified into groups based on the primary location of the emphysematous disease within the lung and acinus (an extensive collection of alveoli that are fed by the terminal bronchioles).  Proximal acinar/centrilobular emphysema refers to the destruction of the central portion of the acinus which has general associations with smoking.  Panacinar emphysema refers to the destruction of all parts of the acinus and is usually related to alpha-1 antitrypsin deficiency. Lastly, the distal acinar or paraseptal emphysema involves the alveolar ducts,  which often occurs in combination with the previous two types of bullous emphysema.[3]

History and Physical

The chief clinical symptom is shortness of breath, but many patients may be asymptomatic. When a patient develops dyspnea, it may be an indication for surgery as the bullae may be occupying over 30% of a hemithorax.[4] The typical patient will be a long-term smoker with dyspnea on exertion and progressive shortness of breath.  Patients will often present with a productive cough, frequently called a "smoker's cough," usually worse in the morning. If a patient presents later on in the disease's progression, they may complain of dyspnea with exertion or wheezing. Physical findings will often include barrel-shaped chest and an increased anterior-posterior diameter of the chest.  There is often a loud P2 heart sound which is a sign of pulmonary hypertension. Finger clubbing may also be present. Edema may be a sign of decreased right ventricular output and cor pulmonale.

Evaluation

Pulmonary function testing is the standard for emphysema evaluation. Forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratios will typically be <0.7.  FVC decreases because of loss of elastic recoil of the lung. There will be an increase in total lung capacity, residual volume, and functional residual capacity, as well as a decrease in vital capacity.  A decrease in diffusing capacity of the lungs for carbon monoxide (DLCO) will often be present because of the destruction of lung interstitium. In a young patient who presents with emphysema, it may be beneficial to test for alpha1-antitrypsin deficiency. A chest x-ray will many times show flattening of the diaphragm because of hyperinflation.  EKG may show right axis deviation, right ventricular hypertrophy or right atrial hypertrophy.  Complete blood count may show increased hemoglobin and hematocrit because of reactive erythrocytosis from chronic hypoxia.  Blood chemistry panels will show increased serum bicarbonate because of metabolic compensation for respiratory acidosis.

Treatment / Management

Chronic medical therapy includes several interventions. First, a short-acting beta agonist such as albuterol is integral for acute shortness of breath and bronchodilation. Anti-muscarinic agents such as tiotropium, ipratropium, and umeclidinium are beneficial as they dry secretions of goblet cells, decrease bronchoconstriction, and inhibit excessive fluid production in bronchi. Long-acting beta agonists like salmeterol and formoterol can be added, but should never be monotherapy. Necessary vaccinations for patients include pneumococcal 13-valent conjugate vaccine given initially and pneumococcal vaccine polyvalent given one year later and a yearly inactivated influenza vaccine. Smoking cessation is beneficial to combat the progression of the disease and decrease mortality. Long-term oxygen is a possible add-on therapy if the pO2 is < 55 or the oxygen saturation is < 88% on a six-minute walk test.

Acute exacerbations should be handled with oxygen, albuterol-ipratropium, and steroids.  Systemic glucocorticoid therapy with a short five-day course of prednisone provides benefit.  ABG is critical to assess for carbon dioxide retention. Chest X-Ray is essential to assess for pneumothorax or new infiltrate requiring antibiotics.  One may also want to explore triggers for these exacerbations such as respiratory infections.

Treatment of bullous emphysema is sometimes surgical. The general indications include moderate or severe dyspnea, a bulla occupying over 30% of the hemithorax and complications such as pneumothorax, infection, and hemoptysis. Where medical management is inadequate, surgical interventions such as lung volume reduction surgery (LVRS) and lung transplantation are needed.[5]

A further option for these patients is lung volume reduction surgery(LVRS).  This procedure involves a wedge excision of emphysematous tissue and is thought to provide benefit by reducing the size of hyperinflated lungs and therefore improving expiratory airflow in the nondiseased lungs.  Studies have shown that elastic recoil of the lungs may improve after LVRS, which in turn improves the expiratory airflow in the lungs. There are extensive criteria for LVRS including notable airflow obstruction on spirometry, evidence of air trapping on lung volume measurements, and CT findings of heterogeneously distributed emphysema.[6][7]

Differential Diagnosis

Differential diagnoses of bullous emphysema which can be mistaken for the disease include asthma which may be ruled out through pulmonary function tests, bronchiectasis which may be visible on imaging, and congestive heart failure.

Complications

Complications of bullous emphysema include pneumothorax, which can be spontaneous, traumatic, or tension in physiology. These are secondary to bullous bleb destruction which releases air into the chest cavity.

Deterrence and Patient Education

The best way to prevent bullous emphysema is by smoking avoidance. Smoking is the most significant cause of this disease process, and smoking history is present in most patients with emphysema.  Patient education should be centered on cessation of smoking if they have a diagnosis of emphysema, but also to counsel all patients on smoking avoidance.

Pearls and Other Issues

Many COPD patients will also have pulmonary cachexia, the definition of which is  BMI <20 or weight <90 percent of ideal body weight. The cachexia is secondary to increased work of breathing. Patients exhibiting these findings will require nutritional support.[8]

Enhancing Healthcare Team Outcomes

An interdisciplinary team ideally performs the management of patients with emphysema and COPD.  Treatment of these patients involves not only their primary care provider but nurses and respiratory therapists.  When patients initiate therapy with inhalers, respiratory therapists prove integral in educating patients on proper use of their inhalers and the use of spacers in conjunction.  Inevitably, if the patient's disease continues to progress, there will be a need to be evaluated by a pulmonologist. Telehealth has also been discussed as a potential avenue for patients, although the cost-effectiveness of this resource still requires further evaluation.[9]


  • Image 7367 Not availableImage 7367 Not available
    Image courtesy S Bhimji MD
Attributed To: Image courtesy S Bhimji MD

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Bullous Emphysema - Questions

Take a quiz of the questions on this article.

Take Quiz
What is the diagnostic test for a patient with a giant bulla compressing the pulmonary parenchyma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following groups of patients with bullous disease will benefit most from surgery?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What is the best method for measuring lung volumes in a patient with severe bullous emphysema?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Bullous Emphysema - References

References

Greenberg JA,Singhal S,Kaiser LR, Giant bullous lung disease: evaluation, selection, techniques, and outcomes. Chest surgery clinics of North America. 2003 Nov     [PubMed]
Palla A,Desideri M,Rossi G,Bardi G,Mazzantini D,Mussi A,Giuntini C, Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up. Chest. 2005 Oct     [PubMed]
van Agteren JE,Carson KV,Tiong LU,Smith BJ, Lung volume reduction surgery for diffuse emphysema. The Cochrane database of systematic reviews. 2016 Oct 14     [PubMed]
    [PubMed]
    [PubMed]
Chronic obstructive pulmonary disease among adults--United States, 2011. MMWR. Morbidity and mortality weekly report. 2012 Nov 23     [PubMed]
Perkins JT,Choate R,Mannino DM,Browning SR,Sandhaus RA, Benefits Among Patients with Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention Program. Chronic obstructive pulmonary diseases (Miami, Fla.). 2016 Dec 24     [PubMed]
Wang K,Pan T,Yang H,Ruan W,Zhong J,Wu G,Zhou X, Assessment of pulmonary microstructural changes by hyperpolarized {sup}129{/sup}Xe diffusion-weighted imaging in an elastase-instilled rat model of emphysema. Journal of thoracic disease. 2017 Aug     [PubMed]
    [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Thoracic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Thoracic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Thoracic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Thoracic. When it is time for the Surgery-Thoracic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Thoracic.